Evidence map›Paper›PMID 28515295›Full record

ArticleJournal of virology2017

Natural Variation of Epstein-Barr Virus Genes, Proteins, and Primary MicroRNA.

Samantha Correia, Anne Palser, Claudio Elgueta Karstegl, Jaap M Middeldorp, Octavia Ramayanti, Jeffrey I Cohen, Allan Hildesheim, Maria Dolores Fellner, Joelle Wiels, Robert E White and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of virology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 1 pooled it
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 1 synthesis or guideline pooled it, 86 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. EBV Genome Variations and Association With Diseases.Journal of medical virology · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. The Epstein-Barr Virus Nuclear Antigen 1 Variant Associated with Nasopharyngeal Carcinoma Defines the Sequence Criteria for Serologic Risk Prediction.Clinical cancer research : an official journal of the American Association for Cancer Research · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Human herpesvirus diversity is altered in HLA class I binding peptides.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 5 countries.

Samantha CorreiaSection of Virology, Imperial College Faculty of Medicine, Norfolk Place, London, United Kingdom.
Anne PalserWellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom.
Claudio Elgueta KarsteglSection of Virology, Imperial College Faculty of Medicine, Norfolk Place, London, United Kingdom.
Jaap M MiddeldorpDepartment of Pathology, VU University Medical Center, Amsterdam, Netherlands.
Octavia RamayantiDepartment of Pathology, VU University Medical Center, Amsterdam, Netherlands.
Jeffrey I CohenLaboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA.
Allan HildesheimInfections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, NCI, Bethesda, Maryland, USA.
Maria Dolores FellnerNational Institute of Infectious Diseases-ANLIS Carlos G. Malbrán, Buenos Aires, Argentina.
Joelle WielsUMR 8126 CNRS, University of Paris-Sud, Institut Gustave Roussy, Villejuif, France.
Robert E WhiteSection of Virology, Imperial College Faculty of Medicine, Norfolk Place, London, United Kingdom.
Paul KellamSection of Virology, Imperial College Faculty of Medicine, Norfolk Place, London, United Kingdom.
Paul J FarrellSection of Virology, Imperial College Faculty of Medicine, Norfolk Place, London, United Kingdom p.farrell@imperial.ac.uk.
Imperial College London · GBAmsterdam UMC Location VUmc · NLWellcome Sanger Institute · GBAdministración Nacional de Laboratorios e Institutos de Salud · ARCentre National de la Recherche Scientifique · FRDivision of Cancer Epidemiology and GeneticsNational Institute of Allergy and Infectious Diseases · US

Funding

Epstein-Barr Virus Associated DisordersZIAAI000913 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI COHEN, JEFFREY · 2009 to 2025
$14.3M
Viral and Host Factors Associated with NPCZIACP010211 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI ENGELS, ERIC A · 2010 to 2025
$6.1M
Medical Research Council MR/N010388/1
6 · The paper itself

Abstract

Viral gene sequences from an enlarged set of about 200 Epstein-Barr virus (EBV) strains, including many primary isolates, have been used to investigate variation in key viral genetic regions, particularly LMP1, Zp, gp350, EBNA1, and the BART microRNA (miRNA) cluster 2. Determination of type 1 and type 2 EBV in saliva samples from people from a wide range of geographic and ethnic backgrounds demonstrates a small percentage of healthy white Caucasian British people carrying predominantly type 2 EBV. Linkage of Zp and gp350 variants to type 2 EBV is likely to be due to their genes being adjacent to the EBNA3 locus, which is one of the major determinants of the type 1/type 2 distinction. A novel classification of EBNA1 DNA binding domains, named QCIGP, results from phylogeny analysis of their protein sequences but is not linked to the type 1/type 2 classification. The BART cluster 2 miRNA region is classified into three major variants through single-nucleotide polymorphisms (SNPs) in the primary miRNA outside the mature miRNA sequences. These SNPs can result in altered levels of expression of some miRNAs from the BART variant frequently present in Chinese and Indonesian nasopharyngeal carcinoma (NPC) samples. The EBV genetic variants identified here provide a basis for future, more directed analysis of association of specific EBV variations with EBV biology and EBV-associated diseases.

Indexed as

Genetic VariationGenotypeEpstein-Barr Virus InfectionsEthnicityGeographyHerpesvirus 4, HumanHumansLondonMicroRNAsMolecular EpidemiologySalivaStudentsUnited StatesViral ProteinsVolunteersMicroRNAsViral ProteinsBZLF1EBNA1Epstein-Barr virusgp350LMP1miRNA

Identifiers

PMID28515295
PMCPMC5512239
OpenAlexW2615198034

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.